EUVIMEDEUVIMED entdecken
KommentarOpen Access · CC BY 4.0

Tumor growth going FAR with KRAS FARnesylation-induced phase separation

Sidhant Kalia, Stéphan Vagner

Cell Reports · 2026-10 · 45 (10) · 117924

DOI: 10.1016/j.celrep.2026.117924 ↗

Kurz gefasst

Kommentar in der Zeitschrift Cell Reports, 2026-10. Verfasst von Sidhant Kalia und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institut Curie, CNRS UMR3348, INSERM U1368, University Paris Saclay, Orsay, France. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins p21(ras), ras Proteins, Protein Prenylation. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins p21(ras)ras ProteinsProtein PrenylationHumansPhase SeparationAnimalsSignal Transduction

Substanzen

Proto-Oncogene Proteins p21(ras)ras ProteinsKRAS protein, human

Autor:innen und Institutionen

  • Institut Curie, CNRS UMR3348, INSERM U1368, University Paris Saclay, Orsay, France.
  • Institut Curie, CNRS UMR3348, INSERM U1368, University Paris Saclay, Orsay, France. Electronic address: stephan.vagner@curie.fr.

Zitieren

APA

Kalia, S., & Vagner, S. (2026). Tumor growth going FAR with KRAS FARnesylation-induced phase separation. Cell Reports, 45(10), 117924. https://doi.org/10.1016/j.celrep.2026.117924

Vancouver

Kalia S, Vagner S. Tumor growth going FAR with KRAS FARnesylation-induced phase separation. Cell Reports. 2026;45(10):117924. doi:10.1016/j.celrep.2026.117924

BibTeX
@article{Kalia2026,
  author = {Kalia, Sidhant and Vagner, Stéphan},
  title = {Tumor growth going FAR with KRAS FARnesylation-induced phase separation},
  journal = {Cell Reports},
  year = {2026},
  volume = {45},
  number = {10},
  pages = {117924},
  doi = {10.1016/j.celrep.2026.117924}
}
Kostenlos starten →